Ramadon Delly, McCrudden Maeliosa T C, Courtenay Aaron J, Donnelly Ryan F
School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia.
Drug Deliv Transl Res. 2022 Apr;12(4):758-791. doi: 10.1007/s13346-021-00909-6. Epub 2021 Jan 20.
Transdermal drug delivery systems have become an intriguing research topic in pharmaceutical technology area and one of the most frequently developed pharmaceutical products in global market. The use of these systems can overcome associated drawbacks of other delivery routes, such as oral and parenteral. The authors will review current trends, and future applications of transdermal technologies, with specific focus on providing a comprehensive understanding of transdermal drug delivery systems and enhancement strategies. This article will initially discuss each transdermal enhancement method used in the development of first-generation transdermal products. These methods include drug/vehicle interactions, vesicles and particles, stratum corneum modification, energy-driven methods and stratum corneum bypassing techniques. Through suitable design and implementation of active stratum corneum bypassing methods, notably microneedle technology, transdermal delivery systems have been shown to deliver both low and high molecular weight drugs. Microneedle technology platforms have proven themselves to be more versatile than other transdermal systems with opportunities for intradermal delivery of drugs/biotherapeutics and therapeutic drug monitoring. These have shown that microneedles have been a prospective strategy for improving transdermal delivery systems.
透皮给药系统已成为制药技术领域一个引人关注的研究课题,也是全球市场上开发最为频繁的药品之一。使用这些系统可以克服其他给药途径(如口服和肠胃外给药)的相关缺点。作者将回顾透皮技术的当前趋势和未来应用,特别着重于全面理解透皮给药系统及其增强策略。本文将首先讨论第一代透皮产品开发中使用的每种透皮增强方法。这些方法包括药物/载体相互作用、囊泡和颗粒、角质层改性、能量驱动方法和角质层绕过技术。通过适当设计和实施有效的角质层绕过方法,特别是微针技术,透皮给药系统已被证明能够递送低分子量和高分子量药物。微针技术平台已证明比其他透皮系统更具通用性,有机会进行药物/生物治疗剂的皮内递送和治疗药物监测。这些都表明微针一直是改善透皮给药系统的一种有前景的策略。